ConductScience.org, home

Paper · 23736366

Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.

Asmar M and 5 others. Int J Obes (Lond), 2014. Cited by 44 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects. Papers, record 23736366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23736366

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
PubMed
Journal
Int J Obes (Lond)
PubMed
Year
2014
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.5
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Asmar MM
2Simonsen LL
3Arngrim NN
4Holst JJJ J
5Dela FF
6Bülow JJ

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastric Inhibitory PolypeptideMajor topic
HyperglycemiaMajor topic
HyperinsulinismMajor topic
Insulin ResistanceMajor topic
ObesityMajor topic
Subcutaneous Fat, AbdominalMajor topic
Adult
Blood Glucose
Glucose Clamp Technique
Glucose Intolerance
Glucose Tolerance Test
Humans
Male
Receptors, Gastrointestinal Hormone
Regional Blood Flow
Triglycerides

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,976,802Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity.Clin Sci (Lond)1996https://conductscience.org/library/papers/8976802PubMed
217,848,629GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.Am J Physiol Endocrinol Metab2007https://conductscience.org/library/papers/17848629PubMed
312,145,159Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity.Diabetes2002https://conductscience.org/library/papers/12145159PubMed
421,815,989Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.Obes Rev2011https://conductscience.org/library/papers/21815989PubMed
520,731,685Real-time contrast-enhanced ultrasound determination of microvascular blood volume in abdominal subcutaneous adipose tissue in man. Evidence for adipose tissue capillary recruitment.Clin Physiol Funct Imaging2010https://conductscience.org/library/papers/20731685PubMed
614,662,716Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans.Circulation2004https://conductscience.org/library/papers/14662716PubMed
719,996,386On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.Am J Physiol Endocrinol Metab2010https://conductscience.org/library/papers/19996386PubMed
820,008,019Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.J Clin Endocrinol Metab2010https://conductscience.org/library/papers/20008019PubMed
912,068,290Inhibition of gastric inhibitory polypeptide signaling prevents obesity.Nat Med2002https://conductscience.org/library/papers/12068290PubMed
1010,938,238Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.Am J Physiol Regul Integr Comp Physiol2000https://conductscience.org/library/papers/10938238PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42,907,720
Glucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature search.
Rev Endocr Metab Disord2026https://conductscience.org/library/papers/42907720PubMed
42,697,203Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.Cell Rep Med2026https://conductscience.org/library/papers/42697203PubMed
42,393,405GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.Diabetologia2026https://conductscience.org/library/papers/42393405PubMed
41,226,777Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis.Int J Mol Sci2025https://conductscience.org/library/papers/41226777PubMed
40,732,974The Complex Gene-Carbohydrate Interaction in Type 2 Diabetes: Between Current Knowledge and Future Perspectives.Nutrients2025https://conductscience.org/library/papers/40732974PubMed
40,469,445The evolution of the therapeutic concept 'GIP receptor antagonism'.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40469445PubMed
38,579,777The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue.J Endocrinol2024https://conductscience.org/library/papers/38579777PubMed
37,592,302GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.Cardiovasc Diabetol2023https://conductscience.org/library/papers/37592302PubMed
36,837,756Relation of Aortic Waveforms with Gut Hormones following Continuous and Interval Exercise among Older Adults with Prediabetes.Metabolites2023https://conductscience.org/library/papers/36837756PubMed
36,509,857Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1.Nat Rev Endocrinol2023https://conductscience.org/library/papers/36509857PubMed

1 to 10 of 26

See all 26 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GIP2,695PubTator's text mininghttps://conductscience.org/library/genes/2695

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23736366

GET https://conductscience.org/api/papers/v1/23736366/references?page=2